Follow The Filings

RANI position history

The shares of Rani Therapeutics (RANI) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, COM CL A

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q4: 78,000 shares, $105K, <0.01% of portfolio, New
  2. 2026 Q1: 78,000 shares, $57K, <0.01% of portfolio
  3. 2026 Q2: 20,700 shares, $16K, <0.01% of portfolio, Reduce −73.5%
  4. 2026 Q3: 20,700 shares, $16K, <0.01% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders